See Instructions for Use for a complete list of warnings, precautions, and contraindications
  • USA
    The Flow Re-Direction Endoluminal Device (FRED®) System is indicated for use in the internal carotid artery from the petrous segment to the terminus for the endovascular treatment of adult patients (22 years of age or older) with wide-necked (neck width ≥ 4 mm or dome-to-neck ratio < 2) saccular or fusiform intracranial aneurysms arising from a parent vessel with a diameter ≥ 2.0 mm and ≤ 5.0 mm.

     

    CANADA
    The Flow Re-Direction Endoluminal Device (FRED) System is indicated for use with or without embolic coils for the treatment of intracranial aneurysms that are not amenable to treatment with surgical clipping with parent vessels that are ≥ 2.0 mm and ≤ 5.0 mm in diameter.

     

    Asian Markets: The products may not be approved in all regions. The orders will be taken only in the regions where the product is approved by local regulatory authorities, as required.